Lack of effect of genetic polymorphisms of SLCO1B1 on the lipid-lowering response to pitavastatin in Chinese patients.
about
Pharmacogenomics of statins: understanding susceptibility to adverse effectsStatin pharmacogenomics: pursuing biomarkers for predicting clinical outcomes.[Pharmacogenomic Biomarkers for the Prediction of Statin Efficacy and Safety].Meta-Analysis of the SLCO1B1 c.521T>C Variant Reveals Slight Influence on the Lipid-Lowering Efficacy of Statins.SLCO1B1 c.388A>G Polymorphism Is Associated with HDL-C Levels in Response to Atorvastatin in Chilean Individuals.Frequencies of single-nucleotide polymorphisms and haplotypes of the SLCO1B1 gene in selected populations of the western balkans.The frequency of SLCO1B1*5 polymorphism genotypes among Russian and Sakha (Yakutia) patients with hypercholesterolemia.Pharmacogenomics of high-density lipoprotein-cholesterol-raising therapies.Impact of SLCO1B1 (OATP1B1) and ABCG2 (BCRP) genetic polymorphisms and inhibition on LDL-C lowering and myopathy of statins.Statin dose in Asians: is pharmacogenetics relevant?Lipid-lowing pharmacogenomics in Chinese patients.Seventeen years of statin pharmacogenetics: a systematic review.Interindividual and interethnic variability in drug disposition: polymorphisms in organic anion transporting polypeptide 1B1 (OATP1B1; SLCO1B1).Comparison of the pharmacokinetics of pitavastatin by formulation and ethnic group: an open-label, single-dose, two-way crossover pharmacokinetic study in healthy Caucasian and Japanese men.
P2860
Q28079822-50F242C7-B47C-483E-A0D0-BB4F5EB29682Q33690357-9524F96B-036C-444F-90CB-A93BC33D38D0Q35158967-13C9A227-7F9E-4A9B-994C-06599B22B320Q35332088-1E286C93-FE8F-475D-953C-AB6861FD36CEQ36184009-6410788A-2590-43CE-9828-6B950058AF0BQ36623470-301AE702-3AC4-43EF-9653-87F5E8A10F86Q36956524-94FF9F82-DEA7-4E37-96AE-DD5C39BB744DQ37695401-935559E2-3ABE-4164-BF49-26B45B65CA2BQ37855801-3272B3D2-2E88-417E-A54D-75FFC3D69A25Q37951651-5BC37AB1-3620-4CEE-8BF2-5C63ED7A40F7Q38129422-20D5CD0A-4FC9-4643-A3BB-606719E461B6Q38670109-26001725-22AC-438B-9498-4C051FDC05C8Q39034284-3CD0FB9B-2293-4968-8A99-61FB9A20CAAFQ42614556-2BC24AF8-3049-44D3-BB7F-A09ADB97AEE6
P2860
Lack of effect of genetic polymorphisms of SLCO1B1 on the lipid-lowering response to pitavastatin in Chinese patients.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 08 February 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Lack of effect of genetic poly ...... avastatin in Chinese patients.
@en
Lack of effect of genetic poly ...... avastatin in Chinese patients.
@nl
type
label
Lack of effect of genetic poly ...... avastatin in Chinese patients.
@en
Lack of effect of genetic poly ...... avastatin in Chinese patients.
@nl
prefLabel
Lack of effect of genetic poly ...... avastatin in Chinese patients.
@en
Lack of effect of genetic poly ...... avastatin in Chinese patients.
@nl
P2093
P2860
P356
P1476
Lack of effect of genetic poly ...... avastatin in Chinese patients.
@en
P2093
Dong-sheng Ou-Yang
Gui-xiang Zhang
Guo-ping Yang
Hong-hao Zhou
Lian-sheng Wang
Zhi-jun Huang
P2860
P2888
P304
P356
10.1038/APS.2009.203
P577
2010-02-08T00:00:00Z